Jefferies Group LLC Standard Biotools Inc. Call Options Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$103 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$79.2 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$23.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$14.5 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $106M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...